Gil M Labrucherie's Net Worth
$21.1 Million
Who is Gil M Labrucherie?
Gil M Labrucherie has an estimated net worth of $21.1 Million. This is based on reported shares across multiple companies, which include ACELYRIN, Inc., NEKTAR THERAPEUTICS, and Rezolute, Inc..
SEC CIK
Gil M Labrucherie's CIK is 0001394875
Past Insider Trading and Trends
2015 was Gil M Labrucherie's most active year for acquiring shares with 14 total transactions. Gil M Labrucherie's most active month to acquire stocks was the month of November. 2019 was Gil M Labrucherie's most active year for disposing of shares, totalling 17 transactions. Gil M Labrucherie's most active month to dispose stocks was the month of October. 2017 saw Gil M Labrucherie paying a total of $2,701,300.00 for 481,000 shares, this is the most they've acquired in one year. In 2017 Gil M Labrucherie cashed out on 655,413 shares for a total of $6,416,728.53, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACELYRIN, Inc. (SLRN) Snapshot price: $4.25
CFO and CBO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
∞
| 40.76K |
—
|
—
| 40.76K |
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NEKTAR THERAPEUTICS (NKTR) Snapshot price: $1.12
SVP, COO & CFOGil M Labrucherie owns 312,905 units of Common Stock which is worth $350,453.60. From 2007 to 2022 Gil M Labrucherie acquired a total of 1,581,783 shares in NEKTAR THERAPEUTICS at a cost of $9,209,772.44, Gil also disposed a total of 1,295,760 shares of NEKTAR THERAPEUTICS equalling to $29,956,951.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +3.75% | 11.3K |
$3.95 | -$68,919.60 | 312.9K |
May 15 - May 16
| |||
Form 4
| -2.45% | -7.58K |
$10.95 | -$82,990.05 | 301.6K |
Feb 16
| |||
Form 4
| +20.66% | 52.95K |
—
|
—
| 309.18K |
Dec 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -8.60% | -24.15K |
$13.10 | -$316,390.84 | 256.68K |
Scheduled
|
Nov 16 - Nov 18
| ||
Form 4
| +16.68% | 40.15K |
—
|
—
| 280.83K |
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 12
| |||
Form 4
| -4.33% | -10.87K |
$13.76 | -$149,480.61 | 240.23K |
Scheduled
|
Aug 16 - Aug 17
| ||
Form 4
| -3.05% | -7.90K |
$18.30 | -$144,533.40 | 251.1K |
May 17
| |||
Form 4
| -2.99% | -7.98K |
$22.37 | -$178,445.49 | 259K |
Feb 16
| |||
Form 4
|
—
|
0
|
$14.33 | -$1,659,629.45 | 266.97K |
Scheduled
|
Feb 2 - Feb 4
| ||
Form 4
| +17.62% | 40K |
—
|
—
| 266.97K |
Dec 18
| |||
Form 4
| -3.52% | -8.28K |
$16.93 | -$140,112.68 | 226.97K |
Nov 16
| |||
Form 4
| -0.84% | -2.00K |
$19.96 | -$39,920.00 | 235.25K |
Scheduled
|
Sep 17
| ||
Form 4
| -3.36% | -8.24K |
$19.67 | -$162,199.15 | 237.25K |
Scheduled
|
Aug 17 - Aug 18
| ||
Form 4
| -3.05% | -7.73K |
$22.54 | -$174,154.77 | 245.49K |
Scheduled
|
May 18 - May 19
| ||
Form 4
| -2.29% | -5.94K |
$22.35 | -$132,714.30 | 253.22K |
Feb 18
| |||
Form 4
| +18.33% | 40.15K |
—
|
—
| 259.16K |
Dec 12
| |||
Form 4
| -3.89% | -8.86K |
$17.97 | -$159,268.11 | 219.01K |
Nov 18
| |||
Form 4
|
—
|
0
|
$13.50 | -$314,500.00 | 227.87K |
Scheduled
|
Nov 13
| ||
Form 4
|
—
|
0
|
$11.52 | -$215,500.00 | 227.87K |
Scheduled
|
Oct 15
| ||
Form 4
| +49.06% | 75K |
—
|
—
| 227.87K |
Oct 1
| |||
Form 4
|
—
|
0
|
$13.87 | -$332,750.00 | 152.87K |
Scheduled
|
Sep 16
| ||
Form 4
| +24.42% | 30K |
$16.31 | $489,300.00 | 152.87K |
Aug 26
| |||
Form 4
| -3.96% | -5.06K |
$18.15 | -$91,893.45 | 122.87K |
Aug 16
| |||
Form 4
|
—
|
0
|
$12.50 | -$264,500.00 | 127.94K |
Scheduled
|
Aug 14
| ||
Form 4
|
—
|
0
|
$20.89 | -$684,000.00 | 127.94K |
Scheduled
|
Jul 10
| ||
Form 4
|
—
|
0
|
$20.46 | -$662,500.00 | 127.94K |
Scheduled
|
Jun 17
| ||
Form 4
| -2.86% | -3.77K |
$31.37 | -$118,170.79 | 127.94K |
May 16
| |||
Form 4
| -2.65% | -3.59K |
$42.39 | -$152,264.88 | 131.7K |
Feb 19
| |||
Form 4
| +26.98% | 28.75K |
—
|
—
| 135.29K |
Dec 14
| |||
Form 4
| -5.76% | -6.51K |
$38.25 | -$249,198.75 | 106.54K |
Nov 16
| |||
Form 4
| +18.68% | 17.79K |
$58.40 | -$479,288.80 | 113.06K |
Aug 15 - Aug 16
| |||
Form 4
| -4.95% | -4.94K |
$83.39 | -$412,029.99 | 94.8K |
May 16
| |||
Form 4
|
—
|
0
|
$47.37 | -$6,602,100.00 | 99.74K |
Scheduled
|
May 1 - May 3
| ||
Form 4
| -3.37% | -3.48K |
$82.94 | -$288,382.38 | 99.74K |
Feb 16
| |||
Form 4
| +33.67% | 26K |
—
|
—
| 103.22K |
Dec 15
| |||
Form 4
| +20.98% | 13.3K |
$44.23 | -$296,252.54 | 76.72K |
Nov 15 - Nov 16
| |||
Form 4
|
—
|
0
|
$17.90 | -$1,573,200.00 | 63.41K |
Scheduled
|
Oct 2
| ||
Form 4
| -4.77% | -3.18K |
$19.32 | -$61,379.64 | 63.41K |
Aug 16
| |||
Form 4
| -4.59% | -3.18K |
$19.55 | -$62,149.45 | 66.09K |
May 16
| |||
Form 4
|
—
|
0
|
$10.93 | -$1,691,449.64 | 69.27K |
Scheduled
|
Mar 2 - Mar 3
| ||
Form 4
| -3.29% | -2.36K |
$13.14 | -$30,997.26 | 69.27K |
Feb 16
| |||
Form 4
| +38.74% | 20K |
—
|
—
| 71.63K |
Dec 13
| |||
Form 4
| -3.13% | -1.65K |
$13.96 | -$23,089.84 | 51.13K |
Nov 16
| |||
Form 4
| -5.89% | -3.31K |
$17.56 | -$58,035.80 | 52.78K |
Aug 16
| |||
Form 4
| +308.75% | 26K |
—
|
—
| 34.42K |
Jul 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +20.20% | 1.33K |
$13.58 | -$11,352.66 | 7.92K |
May 16 - May 17
| |||
Form 4
| +25.50% | 1.34K |
$11.92 | -$9,857.62 | 6.59K |
Feb 16 - Feb 17
| |||
Form 4
|
—
|
0
|
$8.98 | -$58,679.98 | 5.25K |
Scheduled
|
Feb 10
| ||
Form 4
|
—
|
0
|
$10.29 | -$89,369.22 | 5.25K |
Scheduled
|
Jan 19
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
$11.36 | -$406,125.73 | 5.25K |
Scheduled
|
Dec 3
| ||
Form 4
|
—
|
0
|
$10.18 | -$300,366.84 | 4.75K |
Scheduled
|
Nov 11
| ||
Form 4
|
—
|
0
|
$8.92 | -$186,516.84 | 4.75K |
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$9.95 | -$278,760.26 | 4.75K |
Scheduled
|
Sep 23
| ||
Form 4
|
—
|
0
|
$8.94 | -$130,332.03 | 4.75K |
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$9.38 | -$160,003.20 | 4.25K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
$10.84 | -$1,483,800.00 | 4.25K |
Scheduled
|
Nov 28 - Dec 1
| ||
Form 4
|
—
|
0
|
$14.03 | -$21,210.00 | 3.75K |
Scheduled
|
Nov 24
| ||
Form 4
|
—
|
0
|
$12.58 | -$23,760.00 | 3.75K |
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +55.34% | 1.09K |
—
|
—
| 3.06K |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +35.26% | 694 |
$5.57 | -$2,200.15 | 2.66K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
| +57.82% | 721 |
$4.37 | -$1,752.37 | 1.97K |
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Rezolute, Inc. (RZLT) Snapshot price: $4.35
InvestorGil M Labrucherie owns 52,631 units of Common Stock which is worth $228,944.85. From 2019 to 2024 Gil M Labrucherie acquired a total of 52,631 shares in Rezolute, Inc. at a cost of $199,997.80.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4/A
| +5,593.09% | 52.63K |
$3.80 | $199,997.80 | 53.57K |
May 4
| |||
Form 4
|
∞
| 52.63K |
$3.80 | $199,997.80 | 52.63K |
May 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |